Find similar content

Source channel @githubtrending · Post #15412 · Jan 14

#jinja#ansible#ansible_collection#collection#devsec#hacktoberfest#hardening#linux#mysql_hardening#nginx#nginx_hardening#os_hardening#playbook#protection#role#ssh_hardening#sysctl devsec.hardening is an Ansible collection that battle-tests security hardening for Linux (CentOS, AlmaLinux, Rocky, Debian, Ubuntu, etc.), MySQL, Nginx, and SSH, matching DevSec Inspec baselines. Install via `ansible-galaxy collection install devsec.hardening` and apply roles like os_hardening easily. It saves you time by automating secure configs across servers, cuts manual work, boosts compliance, and shrinks attack surfaces for safer systems. https://github.com/dev-sec/ansible-collection-hardening

Hashtags

#jinja #ansible #ansible_collection #collection #devsec #hacktoberfest #hardening #linux #mysql_hardening #nginx #nginx_hardening #os_hardening #playbook #protection #role #ssh_hardening #sysctl

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment